Zimmer Biomet Celebrates Four Decades of Excellence with the 40th Anniversary of the Oxford® Partial Knee System

WARSAW, Ind., June 27, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce the 40th anniversary of the Oxford^® Partial Knee System, the most widely used and clinically proven¹ partial knee replacement system in the world.  A partial knee replacement is a treatment for osteoarthritis (OA) in which one of the knee's three compartments is replaced, whereas with total knee replacement, all three of the knee's compartments are replaced. Studies have shown partial knee replacement patients have better range of motion^2-3, shorter hospital stays with a rapid recovery protocol², and fewer and less severe complications⁴, compared to total knee replacement patients.

"When the ligaments in the knee are present and can be preserved, a partial knee replacement is the optimal choice to restore joint function and normal mobility, while enhancing the speed and comfort of a patient's recovery," said Professor Andrew Price, MA D.Phil FRCS, Consultant Orthopaedic Surgeon and Professor of Musculoskeletal Science at the Nuffield Department of Orthopaedic Surgery at Oxford University, in the United Kingdom. "The Oxford Partial Knee System has been integral to the hundreds of successful partial knee replacements I've performed over the last two decades, and has continued to evolve to yield better procedure outcomes for patients."

Since its launch in 1976 in the UK, the Oxford Partial Knee System has been used in more than 600,000¹ surgeries across 50 countries and featured in more than 280¹ published clinical studies. Zimmer Biomet trains more than 1,500 surgeons¹ on the Oxford Partial Knee System each year, around the world.

"Every eight minutes, across the globe, a patient receives an Oxford Partial Knee, which is a testament to the expert design, trusted performance and unparalleled quality of this legacy implant," said Bart Lagae, Director of Zimmer Biomet Partial Knee Reconstruction. "The advantages and benefits of partial knee replacement are well-documented, and we anticipate growing demand for the Oxford Partial Knee as we shift to outcome-based reimbursement models that acknowledge shorter recovery times, lower pain scores and greater overall patient satisfaction."

Furthermore, every Oxford® Partial Knee comes with the only Lifetime Partial Knee Implant Replacement Warranty^† in the U.S.

For more information on the Oxford Partial Knee System, please visit zimmberbiomet.com.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare.  We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation.  Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues.  Together with healthcare professionals, we help millions of people live better lives.

Zimmer Biomet has operations in more than 25 countries around the world and sells products in more than 100 countries.  For more information, visit zimmerbiomet.com or follow Zimmer Biomet on Twitter at twitter.com/zimmerbiomet.

1. Data on file at Zimmer Biomet

2. Lombardi, A. et al. Is Recovery Faster for Mobile-bearing Unicompartmental than Total Knee Arthroplasty? Clinical Orthopedics and Related Research. 467:1450-57. 2009.

3. Amin A, et al. Unicompartmental or Total Knee Replacement? A Direct Comparative Study of Survivorship and Clinical Outcome at Five Years. JBJS Br. 2006; 88-B; Suppl 1, 100. Published Online.

4. Brown, NM, et al. Total Knee Arthroplasty Has Higher Postoperative Morbidity Than Unicompartmental Knee Arthroplasty: A Multicenter Analysis. The Journal of Arthroplasty. (2012)

† Subject to terms and conditions within the written warranty

The Oxford Partial Knee is intended for use in individuals with osteoarthritis or avascular necrosis limited to the medial compartment of the knee and is intended to be implanted with bone cement. The Oxford Knee is not indicated for use in the lateral compartment or for patients with ligament deficiency. Potential risks include, but are not limited to, loosening, dislocation, fracture, wear, and infection, any of which can require additional surgery.

For complete product information, including indications, contraindications, warnings, precautions and potential adverse effects, see the package insert and www.zimmerbiomet.com.

Cautionary Statement Regarding Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings, including anticipated demand for such products and services and potential clinical successes.  Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties that could cause actual outcomes and results to differ materially.  For a list and description of some of such risks and uncertainties, see our periodic reports filed with the SEC.  These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet's filings with the SEC.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Accordingly, such forward-looking statements speak only as of the date made.  Readers of this news release are cautioned not to place undue reliance on these forward-looking statements, since, while management believes the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this news release.

Logo - http://photos.prnewswire.com/prnh/20150624/225371LOGO

SOURCE Zimmer Biomet Holdings, Inc.

Related Links

http://www.zimmerbiomet.com